RisaKaganMDFACOG, CCD,NCMP

PubMed

• Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to men...
  Antonia Morga, Mayank Ajmera, Emily Gao, Oscar Patterson-Lomba, Angela Zhao, Shayna Mancuso, Emad Siddiqui, Risa Kagan> ;Menopause. 2024 Jan 1
• Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetat...
  Nick Panay, Rossella E Nappi, Petra Stute, Santiago Palacios, Tomasz Paszkowski, Risa Kagan, David F Archer, Julie Héroux, Mitra Boolell> ;Maturitas. 2023 Jun 1
• Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms.
  Michael R McClung, Risa Kagan, Shelli Graham, Brian Bernick, Sebastian Mirkin, Ginger Constantine> ;Menopause. 2022 Feb 14
• 10 citations
  Impact of sleep disturbances on employment and work productivity among midlife women in the US SWAN database: a brief report.
  Risa Kagan, Aki Shiozawa, Andrew J. Epstein, Robert Espinosa> ;Menopause. 2021 Aug 30
• 7 citations
  Hormone therapy for postmenopausal osteoporosis management.
  X Jiang, Risa Kagan> ;Climacteric. 2021 Aug 17
• 5 citations
  Uterine bleeding with hormone therapies in menopausal women: a systematic review.
  James H. Pickar, David F. Archer, Steven R. Goldstein, Risa Kagan, Brian Bernick, Sebastian Mirkin> ;Climacteric. 2020 Sep 7
• 24 citations
  Efficacy and safety of erenumab in women with a history of menstrual migraine
  Jelena M. Pavlovic, Koen Paemeleire, H. Gobel, Jo H. Bonner, Alan M. Rapoport, Risa Kagan, Feng Zhang, Hernan Picard, Daniel D. Mikol> ;The Journal of Headache and Pain. 2020 Aug 3
• 9 citations
  Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases.
  E. Michael Lewiecki, John P. Bilezikian, Risa Kagan, Deborah Krakow, Michael R. McClung, Paul D. Miller, Eric T. Rush, Christopher R. Shuhart, Nelson B. Watts, Elaine ...> ;Journal of Clinical Densitometry. 2020 Jan 1
• 46 citations
  Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause.
  Risa Kagan, Susan Kellogg-Spadt, Sharon J. Parish> ;Drugs & Aging. 2019 Oct 1
• 17 citations
  Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women.
  Risa Kagan, Ginger D. Constantine, Brian Bernick, Sebastian Mirkin> ;Menopause. 2019 Jun 1
• 9 citations
  Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.
  Ginger D. Constantine, Dennis A Revicki, Risa Kagan, James A. Simon, Shelli Graham, Brian Bernick, Sebastian Mirkin> ;Menopause. 2019 May 1
• 7 citations
  TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.
  James A. Simon, R Kagan, David F. Archer, Ginger D. Constantine, Brian Bernick, Shelli Graham, Sebastian Mirkin> ;Climacteric. 2019 Mar 12
• 14 citations
  Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review.
  David Portman, Steven R. Goldstein, Risa Kagan> ;Climacteric. 2019 Jan 2
• 2 citations
  Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.
  Risa Kagan, Paula Abreu, Emma Andrews> ;Postgraduate Medicine. 2018 Oct 3
• 34 citations
  A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.
  Rogerio A. Lobo, David F. Archer, Risa Kagan, Ginger D. Constantine, James H. Pickar, Shelli Graham, Brian Bernick, Sebastian Mirkin> ;Obstetrics and Gynecology. 2018 Jul 1
• 113 citations
  Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society ...
  Stephanie S. Faubion, Lisa Larkin, Cynthia A. Stuenkel, Gloria Bachmann, Lisa Astalos Chism, Risa Kagan, Michael Krychman, Sharon J. Parish, Ann H. Partridge, JoAnn V....> ;Menopause. 2018 Jun 1
• 134 citations
  Estrogen therapy for osteoporosis in the modern era.
  V. A. Levin, X. Jiang, R. Kagan> ;Osteoporosis International. 2018 Mar 8
• 24 citations
  Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial.
  James Simon, David F. Archer, Risa Kagan, Brian Bernick, Shelli Graham, Ginger D. Constantine, Sebastian Mirkin> ;Menopause. 2017 Sep 1
• 2 citations
  Restoring vaginal function in postmenopausal women with genitourinary syndrome of menopause.
  Risa Kagan, Eliza Rivera> ;Menopause. 2017 Sep 1
• 12 citations
  Safety and benefit considerations for menopausal hormone therapy
  James H. Pickar, David F. Archer, Risa Kagan, JoAnn V. Pinkerton, Hugh S. Taylor> ;Expert Opinion on Drug Safety. 2017 Jun 30
• 100 citations
  Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
  Steven R. Cummings, Felicia Cosman, E. Michael Lewiecki, John T. Schousboe, Douglas C. Bauer, Dennis M. Black, Thomas D. Brown, Angela M. Cheung, Kathleen M. Cody, Cyr...> ;Journal of Bone and Mineral Research. 2017 Jan 1
• 9 citations
  Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy
  Hugh S. Taylor, Risa Kagan, Corrado Altomare, Susannah Cort, Andrew G. Bushmakin, Lucy Abraham> ;Menopause. 2017 Jan 1
• 3 citations
  In Reply: Menopausal hormone therapy.
  Laura Lipold, Pelin Batur, Risa Kagan> ;Cleveland Clinic Journal of Medicine. 2016 Nov 1
• 5 citations
  Timing and persistence of effect of conjugated estrogens/bazedoxifene in postmenopausal women.
  Risa Kagan, Barry S. Komm, Kelly A. Ryan, Joanne Lavenberg, Ching-Ray Yu, JoAnn V. Pinkerton> ;Menopause. 2016 Nov 1
• 6 citations
  Is there a time limit for systemic menopausal hormone therapy
  Laura Lipold, Pelin Batur, Risa Kagan> ;Cleveland Clinic Journal of Medicine. 2016 Aug 1
• Join now to see all